CAS 1191951-57-1
:4-Dodécyl-N-1,3,4-thiadiazol-2-ylbenzènesulfonamide
- 4-Dodecyl-N-1,3,4-thiadiazol-2-ylbenzenesulfonamide
- Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-
- PHT 427
Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-
CAS :Formule :C20H31N3O2S2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :409.60904-Dodecyl-N-(1,3,4-Thiadiazol-2-Yl)Benzenesulfonamide
CAS :4-Dodecyl-N-(1,3,4-Thiadiazol-2-Yl)BenzenesulfonamideDegré de pureté :98%Masse moléculaire :409.61g/molPHT-427
CAS :PHT-427 (CS-0223) is a dual Akt (Ki: 2.7 μM) and PDPK1 (Ki: 5.2 μM) inhibitor (high-affinity binding for the PH domains of Akt and PDPK1).Formule :C20H31N3O2S2Degré de pureté :97.54% - >99.99%Couleur et forme :SolidMasse moléculaire :409.61PHT-427
CAS :Produit contrôléApplications PHT-427 is a pleckstrin homology domain inhibitor to Akt and PKB Kinase (PDPK1). It can also be used for therapeutic use and biological study of mathematical modeling and parametric analysis of nanoparticle encapsulation and controlled release of a hydrophobic kinase inhibitor PHT-427.
References Lucero-Acuna, A., et al.: Int J Pharm, 494, 249 (2015)Formule :C20H31N3O2S2Couleur et forme :NeatMasse moléculaire :409.61PHT-427-d4 (Major)
CAS :Produit contrôléFormule :C20H27D4N3O2S2Couleur et forme :NeatMasse moléculaire :413.63Akt Inhibitor XIV
CAS :Akt Inhibitor XIV is a growth factor that regulates cell maturation and protein synthesis. Akt inhibitor XIV has been shown to inhibit the activity of CDK4/6, which are enzymes involved in the control of cell cycle progression. This compound has minimal toxicity, can be taken orally, and has been shown to inhibit tumor growth in xenografts. It is an analog of rapamycin and may also have similar anti-cancer effects as rapamycin.
Formule :C20H31N3O2S2Degré de pureté :Min. 95%Masse moléculaire :409.61 g/mol





